Laureano Molins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laureano Molins has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Gonzalo Vidal
Department of Thoracic Surgery, Hospital Universitari Sagrat Cor, C/Viladomat 288, 08029 Barcelona, Spain
4 shared publications- Juan J. Fibla
Thoracic Surgery, Sagrat Cor University Hospital, Barcelona, Spain
4 shared publications Ana Sierra
Department of Anaesthesia, Hospital Universitari Sagrat Cor, C/Viladomat 288, 08029 Barcelona, Spain
3 shared publications- Carlos Simón
Thoracic Surgery Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain
2 shared publications Jose Manuel Mier
Department of Thoracic Surgery, Hospital Universitari Sagrat Cor, C/Viladomat 288, 08029 Barcelona, Spain
2 shared publications- Juan J. Fibla
Cirugía Torácica, Hospital Universitari Sagrat Cor, Barcelona, España
2 shared publications
Latest Publications
- Open Access
- 1 October 2017
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 25 (suppl_1)
P-157LUNG CANCER SURGERY IN WOMEN: DIFFERENTIAL CHARACTERISTICS AND POSTOPERATIVE COMPLICATIONS IN A PROSPECTIVE MULTICENTRE STUDY
Objectives: To analyse the current incidence of lung cancer in women operated in Spain, the differential characteristics of their postoperative complications and their possible causal factors.
- 1 October 2017
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 25 (suppl_1)
Open AccessP-157LUNG CANCER SURGERY IN WOMEN: DIFFERENTIAL CHARACTERISTICS AND POSTOPERATIVE COMPLICATIONS IN A PROSPECTIVE MULTICENTRE STUDY
Objectives: To analyse the current incidence of lung cancer in women operated in Spain, the differential characteristics of their postoperative complications and their possible causal factors.
- 4 November 2015
- Vol. 71 (1) , 38-45
Minimally invasive treatment of pectus excavatum.
Pectus excavatum (PE) is the most common congenital chest wall deformity. It consists of a concavity of the sternum, and the costal cartilages derived from an unbalanced growth of the costochondral regions of the anterior chest wall. The standard operative treatment for PE has been the Ravitch procedure. This technique requires a long incision in the anterior chest wall and bilateral resection of the affected costal cartilages, needing in most cases a posterior metal bar support. The belief that the treatment of PE is basically esthetic led Donald Nuss to develop in 1998 a minimally invasive surgical treatment based on the skeletal frame plasticity and reshape capacity applied to the thorax. Thereby he deviced a technique involving a retrosternal steel bar modifying the sternum´s concavity and supporting the shape of the amended thorax, all performed through two small incisions at each side of the thorax with the help of a thoracoscope. The bar is maintained from 2 to 3 years, and removed after this period. This procedure obtains >90% of positive results with significant esthetic improvement and patient satisfaction. This minimally surgical approach for PE is to be discussed in this review.
- 4 November 2015
- Vol. 71 (1) , 38-45
Minimally invasive treatment of pectus excavatum.
Pectus excavatum (PE) is the most common congenital chest wall deformity. It consists of a concavity of the sternum, and the costal cartilages derived from an unbalanced growth of the costochondral regions of the anterior chest wall. The standard operative treatment for PE has been the Ravitch procedure. This technique requires a long incision in the anterior chest wall and bilateral resection of the affected costal cartilages, needing in most cases a posterior metal bar support. The belief that the treatment of PE is basically esthetic led Donald Nuss to develop in 1998 a minimally invasive surgical treatment based on the skeletal frame plasticity and reshape capacity applied to the thorax. Thereby he deviced a technique involving a retrosternal steel bar modifying the sternum´s concavity and supporting the shape of the amended thorax, all performed through two small incisions at each side of the thorax with the help of a thoracoscope. The bar is maintained from 2 to 3 years, and removed after this period. This procedure obtains >90% of positive results with significant esthetic improvement and patient satisfaction. This minimally surgical approach for PE is to be discussed in this review.
- 31 March 2013
- Published by Elsevier in Cirugía Española
- Vol. 91 (3) , 184-188
Localización de nódulos pulmonares con arpón guiado por tomografía axial computarizada previa a la resección videotoracoscópica. Experiencia en 52 casos
- 31 March 2013
- Published by Elsevier in Cirugía Española
- Vol. 91 (3) , 184-188
Localización de nódulos pulmonares con arpón guiado por tomografía axial computarizada previa a la resección videotoracoscópica. Experiencia en 52 casos
- 1 March 2012
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 48 (3) , 81-85
Video-Assisted Thoracoscopic Lung Biopsy in the Diagnosis of Interstitial Lung Disease: A Prospective, Multi-Center Study in 224 Patients
- 1 March 2012
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 48 (3) , 81-85
Video-Assisted Thoracoscopic Lung Biopsy in the Diagnosis of Interstitial Lung Disease: A Prospective, Multi-Center Study in 224 Patients
- Open Access
- 11 February 2011
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 40 (4) , 907-911
The efficacy of paravertebral block using a catheter technique for postoperative analgesia in thoracoscopic surgery: a randomized trial☆
Objective: The analgesic scheme combining paravertebral block (PVB) and intravenous non-steroidal anti-inflammatory drug (NSAID) has proven to be effective for postoperative pain control after thoracotomy. The hypothesis tested in this study was that this policy was also suitable to improve pain control after video-assisted thoracic surgery (VATS). Methods: This was a prospective randomized study on 40 patients submitted to three-ports’ VATS for pneumothorax or solitary pulmonary nodule. The sample size was calculated to detect one point of minimum pain score difference with 80% statistical power. Patients were randomly assigned to two groups: (1) paravertebral block group (PVB) (n = 20) – At the end of surgery, a catheter was placed in patients in the thoracic paravertebral space under camera control; they received a bolus of 15 ml of local anesthetic (ropivacaine 0.2%) every 6 h, combined with endovenous metamizol (1 g); and (2) alternate NSAIDs group (AN) (n = 20) – They were treated with paracetamol (1 g) combined with metamizol (1 g) every 6 h. Subcutaneous meperidine (synthetic opioid) was employed as rescue drug. Both groups were comparable in terms of age, sex, pathology, and co-morbidity. Pain level was measured with the visual analog scale (VAS) at 1, 6, 24, and 48 h. Results: No side effects related to any of the two analgesic techniques were noted. Two patients needed rescue meperidine in the AN group, and none in the PVB group. VAS scores were the following: PVB group, VAS 1 h: 1.4 ± 0.8, VAS 6 h: 3.4 ± 1.2, VAS 24 h: 2.6 ± 1.0, VAS 48 h: 2.2 ± 0.9, and mean VAS: 2.4 ± 1.3; AN group, VAS 1 h: 2.8 ± 1.0, VAS 6 h: 4.9 ± 1.3, VAS 24 h: 3.9 ± 1.4, VAS 48 h: 3.3 ± 1.0, and mean VAS: 3.8 ± 1.4. VAS scores were significantly lower at any time in the PVB patients (p ≪ 0.01). Conclusions: The analgesic regimen combining PVB and NSAID provided an excellent level of pain control. Thoracoscopy assisted positioning of the paravertebral catheter is simple and effective, and allows direct visualization of correct delivery of local anesthetic. It represents a valuable addition to any VATS procedure.
- 11 February 2011
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 40 (4) , 907-911
Open AccessThe efficacy of paravertebral block using a catheter technique for postoperative analgesia in thoracoscopic surgery: a randomized trial☆
Objective: The analgesic scheme combining paravertebral block (PVB) and intravenous non-steroidal anti-inflammatory drug (NSAID) has proven to be effective for postoperative pain control after thoracotomy. The hypothesis tested in this study was that this policy was also suitable to improve pain control after video-assisted thoracic surgery (VATS). Methods: This was a prospective randomized study on 40 patients submitted to three-ports’ VATS for pneumothorax or solitary pulmonary nodule. The sample size was calculated to detect one point of minimum pain score difference with 80% statistical power. Patients were randomly assigned to two groups: (1) paravertebral block group (PVB) (n = 20) – At the end of surgery, a catheter was placed in patients in the thoracic paravertebral space under camera control; they received a bolus of 15 ml of local anesthetic (ropivacaine 0.2%) every 6 h, combined with endovenous metamizol (1 g); and (2) alternate NSAIDs group (AN) (n = 20) – They were treated with paracetamol (1 g) combined with metamizol (1 g) every 6 h. Subcutaneous meperidine (synthetic opioid) was employed as rescue drug. Both groups were comparable in terms of age, sex, pathology, and co-morbidity. Pain level was measured with the visual analog scale (VAS) at 1, 6, 24, and 48 h. Results: No side effects related to any of the two analgesic techniques were noted. Two patients needed rescue meperidine in the AN group, and none in the PVB group. VAS scores were the following: PVB group, VAS 1 h: 1.4 ± 0.8, VAS 6 h: 3.4 ± 1.2, VAS 24 h: 2.6 ± 1.0, VAS 48 h: 2.2 ± 0.9, and mean VAS: 2.4 ± 1.3; AN group, VAS 1 h: 2.8 ± 1.0, VAS 6 h: 4.9 ± 1.3, VAS 24 h: 3.9 ± 1.4, VAS 48 h: 3.3 ± 1.0, and mean VAS: 3.8 ± 1.4. VAS scores were significantly lower at any time in the PVB patients (p ≪ 0.01). Conclusions: The analgesic regimen combining PVB and NSAID provided an excellent level of pain control. Thoracoscopy assisted positioning of the paravertebral catheter is simple and effective, and allows direct visualization of correct delivery of local anesthetic. It represents a valuable addition to any VATS procedure.
- Open Access
- 1 November 2009
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 36 (5) , 901-905
A prospective study of analgesic quality after a thoracotomy: paravertebral block with ropivacaine before and after rib spreading☆
Objective: Paravertebral block (PVB) is an effective alternative to epidural analgesia in the management of post-thoracotomy pain. Rib spreading (RS) is an important noxious stimulus considered a major cause of post-thoracotomy pain. Our hypothesis was that a bolus of ropivacaine 0.2% through a paravertebral catheter (PVC) inserted before RS could decrease pain during the first 72 postoperative hours. Methods: The methodology employed was to perform a prospective randomised study of 60 consecutive patients submitted to thoracotomy. Patients were divided in two independent groups (anterior thoracotomy (AT) and posterolateral thoracotomy (PT)). A catheter was inserted under direct vision in the thoracic paravertebral space at the level of incision. In each group, patients were randomised to receive a bolus of 20 ml of ropivacaine 0.2% before rib spreading (pre-RS) or after (post-RS), just before closing the thoracotomy. They postoperatively received 15 ml of ropivacaine 0.2% every 6 h combined with methamizol (every 6 h). Subcutaneous meperidine was employed as a rescue drug. The level of pain was measured with the visual analogue scale (VAS) at 1, 6, 24, 48 and 72 h after surgery. The need of meperidine as a rescue drug and secondary effects were also recorded. Results: We did not register secondary effects in relation to the PVC (paravertebral or cutaneous bleeding or haematoma, respiratory depression, cardiotoxicity, confusion, sedation, urinary retention, nausea, vomiting or pruritus). Seven patients (11.6%) needed meperidine as rescue drug (four pre-RS and three post-RS). The mean VAS values were the following: all cases (n = 60): 4.7 ± 2.0; AT (n = 32): 4.0 ± 2.1; PT (n = 28): 5.6 ± 1.8; pre-RS (n = 30): 4.8 ± 1.9; post-RS (n = 30): 4.6 ± 2.0; AT-pre-RS (n = 16): 4.1 ± 2.0; AT-post-RS (n = 16): 3.9 ± 2.1; PT-pre-RS (n = 14): 5.6 ± 1.6; PT-post-RS (n = 14): 5.4 ± 1.7. Conclusions: Post-thoracotomy analgesia combining PVC and a non-steroidal anti-inflammatory drug is a safe and effective practice. VAS values are acceptable (only 11.6% of patients required meperidine). It prevents the risk of side effects related to epidural analgesia. Patients submitted to AT experienced less pain than those with PT (4.0 vs 5.6; p ≪ 0.01). PVB with ropivacaine before RS got similar VAS values than the block after RS (4.8 vs 4.6; p > 0.05). The moment of the insertion of the PVC does not seem to affect postoperative pain levels.
- 1 November 2009
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 36 (5) , 901-905
Open AccessA prospective study of analgesic quality after a thoracotomy: paravertebral block with ropivacaine before and after rib spreading☆
Objective: Paravertebral block (PVB) is an effective alternative to epidural analgesia in the management of post-thoracotomy pain. Rib spreading (RS) is an important noxious stimulus considered a major cause of post-thoracotomy pain. Our hypothesis was that a bolus of ropivacaine 0.2% through a paravertebral catheter (PVC) inserted before RS could decrease pain during the first 72 postoperative hours. Methods: The methodology employed was to perform a prospective randomised study of 60 consecutive patients submitted to thoracotomy. Patients were divided in two independent groups (anterior thoracotomy (AT) and posterolateral thoracotomy (PT)). A catheter was inserted under direct vision in the thoracic paravertebral space at the level of incision. In each group, patients were randomised to receive a bolus of 20 ml of ropivacaine 0.2% before rib spreading (pre-RS) or after (post-RS), just before closing the thoracotomy. They postoperatively received 15 ml of ropivacaine 0.2% every 6 h combined with methamizol (every 6 h). Subcutaneous meperidine was employed as a rescue drug. The level of pain was measured with the visual analogue scale (VAS) at 1, 6, 24, 48 and 72 h after surgery. The need of meperidine as a rescue drug and secondary effects were also recorded. Results: We did not register secondary effects in relation to the PVC (paravertebral or cutaneous bleeding or haematoma, respiratory depression, cardiotoxicity, confusion, sedation, urinary retention, nausea, vomiting or pruritus). Seven patients (11.6%) needed meperidine as rescue drug (four pre-RS and three post-RS). The mean VAS values were the following: all cases (n = 60): 4.7 ± 2.0; AT (n = 32): 4.0 ± 2.1; PT (n = 28): 5.6 ± 1.8; pre-RS (n = 30): 4.8 ± 1.9; post-RS (n = 30): 4.6 ± 2.0; AT-pre-RS (n = 16): 4.1 ± 2.0; AT-post-RS (n = 16): 3.9 ± 2.1; PT-pre-RS (n = 14): 5.6 ± 1.6; PT-post-RS (n = 14): 5.4 ± 1.7. Conclusions: Post-thoracotomy analgesia combining PVC and a non-steroidal anti-inflammatory drug is a safe and effective practice. VAS values are acceptable (only 11.6% of patients required meperidine). It prevents the risk of side effects related to epidural analgesia. Patients submitted to AT experienced less pain than those with PT (4.0 vs 5.6; p ≪ 0.01). PVB with ropivacaine before RS got similar VAS values than the block after RS (4.8 vs 4.6; p > 0.05). The moment of the insertion of the PVC does not seem to affect postoperative pain levels.
- 1 June 2006
- Vol. 1 (5) , 430-3
The yield of mediastinoscopy with respect to lymph node size, cell type, and the location of the primary tumor.
The aim of this study was to investigate the yield of cervical mediastinoscopy (CM) for pathologically diagnosed non-small cell lung cancer (NSCLC), with respect to lymph node size on computed tomography (CT), cell type, and the location of the primary tumor. We reviewed 142 patients who underwent standard cervical mediastinoscopy from April of 1994 to June of 2003 for pathologically diagnosed NSCLC. The staging yield was determined by the percentage of "positive" CM (metastatic paratracheal or subcarinal nodes). Mediastinoscopy was performed when the lymph node diameter was >1 cm and, since 2001, whenever paratracheal or subcarinal lymph nodes were clearly seen on CT, regardless of size. Group A includes patients with lymph nodes on CT of > or =1 cm. Group B includes patients with lymph nodes of 1 cm), 37.9%, and group B (lymph nodes <1 cm), 8.5% (p < 0.01). With respect to cell type, 16.3% were squamous tumors, 42.9% were adenocarcinomas (p < 0.01), 45.5% were large-cell carcinomas, and 44.4% were other types. With respect to the location of the primary tumor and T stage, there were no statistically significant differences (p = 0.09). When only patients with squamous tumors with no enlarged lymph nodes were considered, staging yield was 3.3% (one of 30), and 19.6% (20 of 102) of patients with a negative CM had positive mediastinal lymph nodes at the time of the resection. The yield was 9.8% (10 of 102 patients) in the territory accessible by CM at the time of the resection (true false negative), and 9.8% (10 of 102 patients) in the territory not accessible by CM. Lymph node size and cell type of primary tumors should be taken into account when selecting patients for staging with standard MC in NSCLC. In patients with squamous-type tumors with lymph nodes <1 cm on CT, CM could be avoided because its low yield.
- 1 June 2006
- Vol. 1 (5) , 430-3
The yield of mediastinoscopy with respect to lymph node size, cell type, and the location of the primary tumor.
The aim of this study was to investigate the yield of cervical mediastinoscopy (CM) for pathologically diagnosed non-small cell lung cancer (NSCLC), with respect to lymph node size on computed tomography (CT), cell type, and the location of the primary tumor. We reviewed 142 patients who underwent standard cervical mediastinoscopy from April of 1994 to June of 2003 for pathologically diagnosed NSCLC. The staging yield was determined by the percentage of "positive" CM (metastatic paratracheal or subcarinal nodes). Mediastinoscopy was performed when the lymph node diameter was >1 cm and, since 2001, whenever paratracheal or subcarinal lymph nodes were clearly seen on CT, regardless of size. Group A includes patients with lymph nodes on CT of > or =1 cm. Group B includes patients with lymph nodes of 1 cm), 37.9%, and group B (lymph nodes <1 cm), 8.5% (p < 0.01). With respect to cell type, 16.3% were squamous tumors, 42.9% were adenocarcinomas (p < 0.01), 45.5% were large-cell carcinomas, and 44.4% were other types. With respect to the location of the primary tumor and T stage, there were no statistically significant differences (p = 0.09). When only patients with squamous tumors with no enlarged lymph nodes were considered, staging yield was 3.3% (one of 30), and 19.6% (20 of 102) of patients with a negative CM had positive mediastinal lymph nodes at the time of the resection. The yield was 9.8% (10 of 102 patients) in the territory accessible by CM at the time of the resection (true false negative), and 9.8% (10 of 102 patients) in the territory not accessible by CM. Lymph node size and cell type of primary tumors should be taken into account when selecting patients for staging with standard MC in NSCLC. In patients with squamous-type tumors with lymph nodes <1 cm on CT, CM could be avoided because its low yield.
- Open Access
- 1 March 2006
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 29 (3) , 271-275
Outpatient thoracic surgical programme in 300 patients: clinical results and economic impact☆
Objective: To evaluate clinical aspects, results and the economic impact of the outpatient thoracic surgery programme (OTSP) developed in our Department. Methods: Prospective study of 300 patients who entered in the OTSP from April 2001 to March 2005. The procedures performed were videomediastinoscopy (MC), videothoracoscopic lung biopsy (LB) and videothoracoscopic bilateral thoracic sympathectomy (TS). All procedures were performed under general anaesthesia and patients were discharged in 4–6 h. We analyse demographic data, the substitution index (SI), the admission rate (AR) and readmission rate (RR) after the procedure. We calculate the economic impact of stay expenses on our hospital and on other Spanish hospitals. Results: The female/male ratio of the 300 patients was 83/217, with a mean age of 58.1 years (range: 15–85 years). There were no deaths. Mediastinoscopy was performed as outpatient procedure in 210 patients (mean age: 65.6 years) out of 244 total MC (SI = 86.1%). Two patients were admitted (AR = 0.95%) to observe a minimal pneumothorax and because of late night end. There were no readmissions after MC (RR = 0%). We included 32 ambulatory patients for lung biopsy (mean age: 61.5 years) out of 64 total LB (SI = 50.0%). One patient was admitted because of air leak (AR = 3.1%) and there were no readmissions after LB (RR = 0%). Fifty-eight patients were included in the OTSP for bilateral sympathectomy (mean age: 27.1 years) out of 83 total TS (SI = 69.9%); there were no admissions (AR = 0%) and one patient was readmitted after 9 days because of a hemothorax (RR = 1.7%). Sixty-four patients out of the 91 not included in the OTSP were included in an ‘afternoon surgical programme’ and dismissed the morning after surgery, without contraindication for their inclusion in the OTSP. The hospital's total stay saving was \#8364;12,668 (\#8364;88,226 if performed elsewhere), \#8364;42 per patient (\#8364;294 per patient if performed elsewhere). Conclusion: Video-assisted mediastinoscopy, lung biopsy and bilateral sympathectomy can be included safely in outpatient thoracic surgical programmes. The impact of the economic benefit of OTSP over the conventional hospitalisation depends on the Department's previous policy on hospital stays. Further experience is needed to increase the substitution index and expand the OTSP to other procedures.
- 1 March 2006
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 29 (3) , 271-275
Open AccessOutpatient thoracic surgical programme in 300 patients: clinical results and economic impact☆
Objective: To evaluate clinical aspects, results and the economic impact of the outpatient thoracic surgery programme (OTSP) developed in our Department. Methods: Prospective study of 300 patients who entered in the OTSP from April 2001 to March 2005. The procedures performed were videomediastinoscopy (MC), videothoracoscopic lung biopsy (LB) and videothoracoscopic bilateral thoracic sympathectomy (TS). All procedures were performed under general anaesthesia and patients were discharged in 4–6 h. We analyse demographic data, the substitution index (SI), the admission rate (AR) and readmission rate (RR) after the procedure. We calculate the economic impact of stay expenses on our hospital and on other Spanish hospitals. Results: The female/male ratio of the 300 patients was 83/217, with a mean age of 58.1 years (range: 15–85 years). There were no deaths. Mediastinoscopy was performed as outpatient procedure in 210 patients (mean age: 65.6 years) out of 244 total MC (SI = 86.1%). Two patients were admitted (AR = 0.95%) to observe a minimal pneumothorax and because of late night end. There were no readmissions after MC (RR = 0%). We included 32 ambulatory patients for lung biopsy (mean age: 61.5 years) out of 64 total LB (SI = 50.0%). One patient was admitted because of air leak (AR = 3.1%) and there were no readmissions after LB (RR = 0%). Fifty-eight patients were included in the OTSP for bilateral sympathectomy (mean age: 27.1 years) out of 83 total TS (SI = 69.9%); there were no admissions (AR = 0%) and one patient was readmitted after 9 days because of a hemothorax (RR = 1.7%). Sixty-four patients out of the 91 not included in the OTSP were included in an ‘afternoon surgical programme’ and dismissed the morning after surgery, without contraindication for their inclusion in the OTSP. The hospital's total stay saving was \#8364;12,668 (\#8364;88,226 if performed elsewhere), \#8364;42 per patient (\#8364;294 per patient if performed elsewhere). Conclusion: Video-assisted mediastinoscopy, lung biopsy and bilateral sympathectomy can be included safely in outpatient thoracic surgical programmes. The impact of the economic benefit of OTSP over the conventional hospitalisation depends on the Department's previous policy on hospital stays. Further experience is needed to increase the substitution index and expand the OTSP to other procedures.